Replies to post #113283 on Biotech Values

[DewDiligence]

(CLDA)—the bisphosphonates have been around for years, making an analysis of long-terms benefits (and risks) an easier task.

The same can be said of the mainstream antidepressants, some of which have safety data spanning more than two decades. This is one reason I think CLDA’s Vilazodone is destined to be a commercial dog.